Curanex Pharmaceuticals Inc Share Price

Curanex Pharmaceuticals Inc Share Price

NASDAQ: CURX | Micro Cap
$5.36
+$0.29 (5.62%) Last updated on 31 Oct, 2026 | 00:16 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Curanex Pharmaceuticals Inc Stock Performance

Open
$5.36
Prev. Close
$5.07
Circuit Range
N/A
Day Range
$5.36 - $5.36
Year Range
$0.18 - $6.45
Volume
100
Average Traded
$5.36

Curanex Pharmaceuticals Inc Share Price Today

As of 31 October 2026, Curanex Pharmaceuticals Inc's share price is $5.36. The stock opened at $5.36, compared to its previous close of $5.07. During today's trading session, Curanex Pharmaceuticals Inc's share price traded between $5.36 and $5.36, with an average price of $5.36. Over the past 52 weeks, the stock has recorded a high of $6.45 and a low of $0.18. In terms of performance, Curanex Pharmaceuticals Inc's share price has risen by 1181.10% over the last six months and is up 677.21% on a year-on-year basis.

Curanex Pharmaceuticals Inc Share Price Chart

Line chart of the Curanex Pharmaceuticals Inc price trend over the selected period. The price rose overall, ranging from 5.36 to 5.36, ending at 5.36.
$5.36$5.36
L
Show Current Price
H

Curanex Pharmaceuticals Inc Stock Fundamentals & Key Indicators

Market Cap
$136.54M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-6.68
Revenue (TTM)
$0.00
Return On Equity (TTM)
-218.65%
Profit Margin
N/A
Debt to Equity
0.00
Quarterly Earnings Growth YoY
-246.32%

Curanex Pharmaceuticals Inc Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$0.00$0.00$0.00$0.00
Net Profit-$0.95-$3.07-$3.15-$3.29
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A-223.16%-2.61%-4.44%

Curanex Pharmaceuticals Inc Annual Profit & Loss

All figures in USD

Particulars2025
Revenue$0.00
Net Profit-$4.23
Net Profit MarginN/A
Income ChangeN/A

About Curanex Pharmaceuticals Inc

Curanex Pharmaceuticals Inc is engaged in discovering, developing, and commercializing botanical drugs for treating unmet medical needs in patients with inflammatory disease. Its compound, Phyto-N, is in preclinical research for six indications: ulcerative colitis, atopic dermatitis, COVID-19, type 2 diabetes, nonalcoholic fatty liver disease (NAFLD) and gout. Phyto-N, is a proprietary botanical extract with chemical components and pharmacological activities that harnesses potential anti-inflammatory properties of a medicinal plant.

Curanex Pharmaceuticals Inc Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Oct 2026
$4.72
$5.36
+16.67%
Sep 2026
$4.70
$4.59
+2,025.00%
Aug 2026
$0.22
$0.22
+5.37%
Jul 2026
$0.27
$0.20
-25.45%
Jun 2026
$0.33
$0.28
-16.92%
May 2026
$0.40
$0.33
-20.81%
Apr 2026
$0.52
$0.42
-13.46%
Mar 2026
$0.43
$0.48
+7.33%
Feb 2026
$0.35
$0.45
+38.89%
Jan 2026
$0.37
$0.32
-2.70%
Dec 2025
$0.46
$0.33
-32.04%
Nov 2025
$0.65
$0.49
-28.88%

CURX Share Price FAQs